AAAAAA

   
Results: 1-7 |
Results: 7
Comparison of cytogenetic and molecular genetic detection of t(8;21) and inv(16) in a prospective series of adults with de novo acute myeloid leukemia: A cancer and leukemia group B study
Authors: Mrozek, K Prior, TW Edwards, C Marcucci, G Carroll, AJ Snyder, PJ Koduru, PRK Theil, KS Pettenati, MJ Archer, KJ Caligiuri, MA Vardiman, JW Kolitz, JE Larson, RA Bloomfield, CD
Citation: K. Mrozek et al., Comparison of cytogenetic and molecular genetic detection of t(8;21) and inv(16) in a prospective series of adults with de novo acute myeloid leukemia: A cancer and leukemia group B study, J CL ONCOL, 19(9), 2001, pp. 2482-2492
Impact of therapy with chlorambucil, fludarabine, or fludarabine plus chlorambucil on infections in patients with chronic lymphocytic leukemia: Intergroup Study Cancer and Leukemia Group B 9011
Authors: Morrison, VA Rai, KR Peterson, BL Kolitz, JE Elias, L Appelbaum, FR Hines, JD Shepherd, L Martell, RE Larson, RA Schiffer, CA
Citation: Va. Morrison et al., Impact of therapy with chlorambucil, fludarabine, or fludarabine plus chlorambucil on infections in patients with chronic lymphocytic leukemia: Intergroup Study Cancer and Leukemia Group B 9011, J CL ONCOL, 19(16), 2001, pp. 3611-3621
BAALC, the human member of a novel mammalian neuroectoderm gene lineage, is implicated in hematopoiesis and acute leukemia
Authors: Tanner, SM Austin, JL Leone, G Rush, LJ Plass, C Heinonen, K Mrozek, K Sill, H Knuutila, S Kolitz, JE Archer, KJ Caligiuri, MA Bloomfield, CD de la Chapelle, A
Citation: Sm. Tanner et al., BAALC, the human member of a novel mammalian neuroectoderm gene lineage, is implicated in hematopoiesis and acute leukemia, P NAS US, 98(24), 2001, pp. 13901-13906
Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: A cancer and leukemia group B study
Authors: Whitman, SP Archer, KJ Feng, L Baldus, C Becknell, B Carlson, BD Carroll, AJ Mrozek, K Vardiman, JW George, SL Kolitz, JE Larson, RA Bloomfield, CD Caligiuri, NA
Citation: Sp. Whitman et al., Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: A cancer and leukemia group B study, CANCER RES, 61(19), 2001, pp. 7233-7239
High frequency of immunophenotype changes in acute myeloid leukemia at relapse: implications for residual disease detection (Cancer and Leukemia Group B Study 8361)
Authors: Baer, MR Stewart, GC Dodge, RK Leget, G Sule, N Mrozek, K Schiffer, CA Powel, BL Kolitz, JE Moore, JO Stone, RM Davey, FR Carrol, AJ Larson, RA Bloomfield, CD
Citation: Mr. Baer et al., High frequency of immunophenotype changes in acute myeloid leukemia at relapse: implications for residual disease detection (Cancer and Leukemia Group B Study 8361), BLOOD, 97(11), 2001, pp. 3574-3580
Novel methylation targets in de novo acute myeloid leukemia with prevalence of chromosome 11 loci
Authors: Rush, LJ Dai, ZY Smiraglia, DJ Gao, X Wright, FA Fruhwald, M Costello, JF Held, WA Yu, L Krahe, R Kolitz, JE Bloomfield, CD Caligiuri, MA Plass, C
Citation: Lj. Rush et al., Novel methylation targets in de novo acute myeloid leukemia with prevalence of chromosome 11 loci, BLOOD, 97(10), 2001, pp. 3226-3233
Extended Rituximab (anti-CD20 monoclonal antibody) therapy for relapsed orrefractory low-grade or follicular non-Hodgkin's lymphoma
Authors: Piro, LD White, CA Grillo-Lopez, AJ Janakiraman, N Saven, A Beck, TM Varns, C Shuey, S Czuczman, M Lynch, JW Kolitz, JE Jain, V
Citation: Ld. Piro et al., Extended Rituximab (anti-CD20 monoclonal antibody) therapy for relapsed orrefractory low-grade or follicular non-Hodgkin's lymphoma, ANN ONCOL, 10(6), 1999, pp. 655-661
Risultati: 1-7 |